Michaela Fontenay

18PUBLICATIONS
121CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunologyPredictive and prognostic markersMedical mycologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 13, 2026
Inhibition of PHB2/PINK1-mediated mitophagy potentiates venetoclax activity in acute myeloid leukemia.

|May 04, 2026
High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.

|Jan 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

David Rombaut, Sarah Sandmann, Tobias Tekath

|Jul 03, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Elsa Bernard, Robert P Hasserjian, Peter L Greenberg

|Apr 08, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.

David Rombaut, Carine Lefèvre, Tony Rached

|Oct 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini

Pageof 3

Frequent Collaborators

4 joint publications

Michael R Savona

4 joint publications

Jacqueline Boultwood

4 joint publications

Christina Ganster

4 joint publications

Monika Belickova